
AVTX Valuation
Avalo Therapeutics Inc
- Overview
- Forecast
- Valuation
- Earnings
AVTX Relative Valuation
AVTX's fair value is calculated using relative valuation, based on historical P/E and P/S ranges and their premiums/discounts relative to a competitor average, adjusted by weights. If the market price exceeds this fair value range, AVTX is overvalued; if below, it's undervalued.
Historical Valuation
Avalo Therapeutics Inc (AVTX) is now in the Fair zone, suggesting that its current forward PS ratio of 0.00 is considered Fairly compared with the five-year average of -2.49. The fair price of Avalo Therapeutics Inc (AVTX) is between NaN to NaN according to relative valuation methord.
Relative Value
Fair Zone
NaN-NaN
Current Price:6.69
Fair
Trailing
Forward
P/E
P/E
EV/EBITDA
EV/EBIT
P/S
P/OCF
P/FCF
1Y
3Y
5Y
Trailing
Forward
0.59
P/B
Median3y
-2.74
Median5y
25.49
-72.87
FCF Yield
Median3y
-209.38
Median5y
-140.08
Competitors Valuation Multiple
The average P/S ratio for AVTX's competitors is 3.08, providing a benchmark for relative valuation. Avalo Therapeutics Inc Corp (AVTX) exhibits a P/S ratio of 0.00, which is -100.00% above the industry average. Given its robust revenue growth of %, this premium appears unsustainable.
P/S
P/E
EV/EBITDA
EV/EBIT
P/S
People Also Watch

VGZ
Vista Gold Corp
0.945
USD
-0.53%

PRE
Prenetics Global Ltd
8.060
USD
0.00%

NB
NioCorp Developments Ltd
3.140
USD
-1.26%

SDIG
Stronghold Digital Mining Inc
0
USD
+3.20%

GNTA
Genenta Science SPA
3.780
USD
-0.79%

BYSI
Beyondspring Inc
1.920
USD
-1.54%

FTII
Futuretech II Acquisition Corp
0
USD
-0.18%

MGLD
Marygold Companies Inc
0.830
USD
-10.95%

ICCM
Icecure Medical Ltd
1.070
USD
+8.63%

ANVS
Annovis Bio Inc
2.890
USD
+1.40%
FAQ

Is Avalo Therapeutics Inc (AVTX) currently overvalued or undervalued?
Avalo Therapeutics Inc (AVTX) is now in the Fair zone, suggesting that its current forward PS ratio of 0.00 is considered Fairly compared with the five-year average of -2.49. The fair price of Avalo Therapeutics Inc (AVTX) is between NaN to NaN according to relative valuation methord.

What is Avalo Therapeutics Inc (AVTX) fair value?

How does AVTX's valuation metrics compare to the industry average?

What is the current P/B ratio for Avalo Therapeutics Inc (AVTX) as of Jul 27 2025?

What is the current FCF Yield for Avalo Therapeutics Inc (AVTX) as of Jul 27 2025?

What is the current Forward P/E ratio for Avalo Therapeutics Inc (AVTX) as of Jul 27 2025?
